Does PALBOCICLIB Cause Treatment failure? 237 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 237 reports of Treatment failure have been filed in association with PALBOCICLIB (Ibrance). This represents 0.3% of all adverse event reports for PALBOCICLIB.
237
Reports of Treatment failure with PALBOCICLIB
0.3%
of all PALBOCICLIB reports
5
Deaths
6
Hospitalizations
How Dangerous Is Treatment failure From PALBOCICLIB?
Of the 237 reports, 5 (2.1%) resulted in death, 6 (2.5%) required hospitalization, and 10 (4.2%) were considered life-threatening.
Is Treatment failure Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 237 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Treatment failure?
METHOTREXATE (14,672)
ETANERCEPT (11,893)
ADALIMUMAB (9,990)
ABATACEPT (9,301)
RITUXIMAB (9,217)
TOCILIZUMAB (9,097)
HYDROXYCHLOROQUINE (8,786)
LEFLUNOMIDE (8,686)
INFLIXIMAB (8,535)
SULFASALAZINE (7,423)
Which PALBOCICLIB Alternatives Have Lower Treatment failure Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID